Target intelligence / Profile preview

TBC1 domain family member 3J, pseudogene (TBC1D3JP)

Target: TBC1D3JP
Molecular classification: Other (pseudogene)

Overview

TBC1 domain family member 3J, pseudogene (TBC1D3JP), is a pseudogene annotated in the human genome, related to the TBC1D3 gene family, which encodes proteins containing a TBC (Tre-2, Bub2, and Cdc16) domain but is itself a non-functional, non-protein-coding copy. The TBC1D3 family as a whole has multiple functional paralogs implicated in cell proliferation, oncogenesis, and human brain evolution, but this pseudogene does not have a known biological function or disease association and is not considered a therapeutic target[1][2][3].

Other names: TBC1D3JPTBC1D3JTBC1 domain family member 3J

Beyond the preview

Go deeper on TBC1 domain family member 3J, pseudogene (TBC1D3JP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 3J, pseudogene (TBC1D3JP).

Explore the full profile